N-Methyl-3-nitropyridin-2-amine, 95.0%, 5g

4-Methoxyisobenzofuran-1(3H)-one, 95.0%, 1g

1,2-Dichloro-3-methylbenzene, 95.0%, 100g

GC capillary column ROTI®Cap-1701, 25 m, 0.20 mm, 0.20 µm, 1 Piece(s)

3-methyl-2-(pyrrolidin-1-yl)butan-1-amine; oxalic acid, 95.0%, 2.5g

2,4-dichloro-6-methyl-1,3,5-triazine, 95.0%, 25g

2-Chloro-1-(5-methoxy-1H-indol-3-yl)-ethanone, 98.0%, 1g

(2S,4S)-4-Hydroxypyrrolidine-2-carboxamide hydrochloride, 98%, 100mg

1H-INDAZOLE, 4-BROMO-6-IODO-, 95%, 500mg

2-[4-(3-Chlorophenyl)piperazin-1-yl]-2-(4-fluorophenyl)acetic acid, 250mg

ETHYL 8-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBOXYLATE, 95.0%, 10g

2-((2R,3R)-3-(TERT-BUTYL)-4-(3,5-DICYCLOPENTYL-2,6-DIMETHOXYPHENYL)-2,3-DIHYDROBENZO[D][1,3]OXAPHOSPHOL-2-YL)PROPAN-2-OL, 95%, 500mg

Titanocene dichloride, 97.0%, 500g